Background: The response of ovarian cancer patients to carboplatin and paclitaxel is variable, necessitating identification of biomarkers that may reliably predict drug sensitivity and resistance. xenografts. In HOX424, apoptosis and cell routine had been upregulated, whereas Wnt signalling was inhibited. Genes downregulated after day time 7 from both xenografts had been predictive of general success.… Continue reading Background: The response of ovarian cancer patients to carboplatin and paclitaxel